Preparation method of 2-hydroxyethylaminocaproic acid ester compound and its application
The novel preparation method for 2-hydroxyethylaminocaproic acid ester compounds enhances mRNA delivery efficiency by addressing enzymatic degradation and cell membrane barriers, improving organ targeting and distribution.
Patent Information
- Application Number
- JP2025514138
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-09-19
- Filing Date
- 2023-09-19
- Publication Date
- 2025-09-19
AI Technical Summary
Current methods for delivering in vitro synthesized mRNA into cells face challenges such as enzymatic degradation and cell membrane barriers, and existing ionizable lipids for liposome-mediated nucleic acid delivery systems have limitations in organ targeting.
A novel method for preparing 2-hydroxyethylaminocaproic acid ester compounds by reacting specific compounds under reducing agent conditions, using sodium borohydride or sodium triacetoxyborohydride, and incorporating a base like N,N-diisopropylethylamine, to enhance the delivery efficiency and organ targeting of mRNA.
The prepared compounds improve the delivery efficiency of mRNA by overcoming enzymatic degradation and cell membrane barriers, achieving better distribution in target organs like the liver and reducing accumulation in the spleen.
Smart Images

Figure 2025531089000001_ABST